tolvaptan has been researched along with Small Cell Lung Carcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, M; Schulz, C; Utpatel, K | 1 |
| Garrahy, A; Hannon, AM; Thompson, CJ; Williams, DJ; Zia-Ul-Hussnain, HM | 1 |
| Ichikawa, D; Kai, K; Koitabashi, K; Shibagaki, Y; Tominaga, N | 1 |
| Grohé, C; Lüders, H; Petereit, C; Teber, I; Zaba, O | 1 |
| Hiddemann, W; Schnaiter, A | 1 |
| Ardizzoni, A; Bordi, P; Buti, S; Regolisti, G; Tiseo, M | 1 |
| Bohnet, S; Brabant, G; Haas, CS; Kenz, S; Werth, SC | 1 |
2 trial(s) available for tolvaptan and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan | 2013 |
High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH).
Topics: Aged; Aged, 80 and over; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Natriuretic Agents; Paraneoplastic Endocrine Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2011 |
5 other study(ies) available for tolvaptan and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors | 2018 |
Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Resistance; Fatal Outcome; Female; Genetic Diseases, X-Linked; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Sodium; Tolvaptan; Vasopressins | 2018 |
Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Patient Discharge; Quality of Life; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2019 |
[Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2014 |
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chemoradiotherapy; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Middle Aged; Remission Induction; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome | 2015 |